Welcome to our dedicated page for Keurig Dr Pepper SEC filings (Ticker: KDP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Keurig Dr Pepper Inc. (NASDAQ: KDP) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures, including current reports on Form 8‑K and other key documents filed with the U.S. Securities and Exchange Commission. These filings give investors and analysts insight into material events, financing arrangements, leadership changes and transaction details affecting the beverage and coffee business.
Recent Form 8‑K filings describe several important developments. KDP has reported the declaration of regular quarterly cash dividends on its common stock and the appointment of a new Chief Financial Officer, including related compensation arrangements and transition agreements. The company has also filed 8‑Ks covering leadership changes in its U.S. Coffee segment and the appointment of a Chief Transformation and Supply Chain Officer.
For corporate transactions, Keurig Dr Pepper’s 8‑Ks outline the merger protocol for its recommended public cash offer to acquire all issued ordinary shares of JDE Peet’s N.V., including offer terms, conditions, post‑closing restructuring options and related irrevocable undertakings. Additional filings detail a bridge credit agreement intended to fund the acquisition and an investment agreement for Series A Convertible Perpetual Preferred Stock with investors affiliated with Apollo and KKR, including dividend terms, conversion mechanics, redemption rights and transfer restrictions.
Litigation and other matters are also addressed in KDP’s current reports, such as updates on multidistrict antitrust litigation related to Keurig Green Mountain single‑serve coffee. On Stock Titan, these filings are supplemented with AI‑powered summaries that explain the significance of each document, helping users quickly understand dividend actions, financing structures, executive changes, transaction steps and legal developments without reading every page of the original SEC text.
Sandler Debra A. reported acquisition or exercise transactions in this Form 4 filing.
Keurig Dr Pepper Inc. director Debra A. Sandler received a grant of 6,062 restricted stock units on March 4, 2026. These units were awarded at no cash cost per unit.
Subject to vesting conditions and exceptions, the restricted stock units are scheduled to vest on March 4, 2031, with each unit representing a contingent right to receive one share of Keurig Dr Pepper common stock upon vesting.
Keurig Dr Pepper Inc. director Michael G. Van de Ven reported an equity compensation grant of 6,062 restricted stock units on March 4, 2026. These units were awarded at no exercise price and increase his directly held derivative position to 6,062 units.
According to the footnote, the restricted stock units vest on March 4, 2031, subject to certain vesting conditions and exceptions. Each unit represents a contingent right to receive one share of Keurig Dr Pepper common stock once vesting requirements are met, so this filing reflects a long‑term incentive award rather than an open‑market share purchase.
Boston Oray reported acquisition or exercise transactions in this Form 4 filing.
Keurig Dr Pepper Inc. director Boston Oray received a grant of 6,062 restricted stock units of company stock. According to the terms, these units are scheduled to vest on March 4, 2031, subject to certain vesting conditions and exceptions. Each unit represents a contingent right to receive one share of Keurig Dr Pepper common stock when it vests.
Whiting Lawson E reported acquisition or exercise transactions in this Form 4 filing.
Keurig Dr Pepper Inc. director Lawson E. Whiting reported receiving a grant of 6,062 restricted stock units on March 4, 2026. The award was recorded at a price of $0.00 per unit, reflecting a compensatory grant rather than an open-market purchase.
According to the terms, these 6,062 restricted stock units are scheduled to vest on March 4, 2031, subject to certain vesting conditions and exceptions. Each unit represents a contingent right to receive one share of Keurig Dr Pepper common stock upon vesting, so no shares are issued until the vesting requirements are met.
Keurig Dr Pepper Inc. director Robert S. Singer reported equity compensation activity involving restricted stock units and common shares. On March 4, 2026, he received a grant of 6,062 restricted stock units, each representing the right to receive one share of common stock upon future vesting, currently scheduled for March 4, 2031 subject to vesting conditions.
On March 3, 2026, 5,226 restricted stock units previously granted on March 3, 2021 fully vested and were converted into 5,226 shares of common stock on a one-for-one basis under the company’s Omnibus Stock Incentive Plan of 2019. Following these transactions, he holds 47,829 shares of common stock directly and 12,499 shares indirectly through the Robert Singer 2005 Insurance Trust.
Keurig Dr Pepper Inc. director Pamela H. Patsley reported equity compensation activity involving restricted stock units and common shares. On March 4, 2026, she received a grant of 10,392 restricted stock units, each representing a contingent right to one share of common stock, which are scheduled to vest on March 4, 2031 subject to vesting conditions.
On March 3, 2026, 5,226 restricted stock units granted on March 3, 2021 fully vested and were converted into 5,226 shares of common stock on a one-for-one basis under the Omnibus Stock Incentive Plan of 2019. After these transactions, she directly owned 44,992 shares of common stock and 10,392 restricted stock units.
Keurig Dr Pepper Inc. director Juliette Hickman reported equity compensation transactions involving restricted stock units. On
Keurig Dr Pepper director Robert James Gamgort reported equity award activity involving restricted stock units and common shares. On March 2 and 3, he exercised several batches of restricted stock units, converting 30,699, 82,481, and 24,346 RSUs into common stock at no cash exercise price under the company’s Omnibus Stock Incentive Plan.
To cover applicable tax obligations upon vesting, he disposed of 12,081 and 42,038 common shares through share withholding transactions at prices of $29.57 and $29.97 per share, respectively, which are characterized as tax-withholding dispositions rather than open‑market sales. After these transactions, he directly held 1,942,875 common shares and also reported indirect ownership of additional shares held by 2024 and 2025 Trusts.
Keurig Dr Pepper Inc. filed an initial insider ownership report for Amie Thuener O'Toole, who is listed as a director of the company. This Form 3 filing establishes her reporting status as an insider. The data provided does not show any share transactions or holdings details.
Keurig Dr Pepper Inc. director William A. Newlands filed an initial statement of beneficial ownership on Form 3. The filing lists him as a director of the company and does not report any buy, sell, acquisition, or disposition transactions in Keurig Dr Pepper securities.